The role of lipids in Parkinson's disease

H Xicoy, B Wieringa, GJM Martens - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disease characterized by a progressive
loss of dopaminergic neurons from the nigrostriatal pathway, formation of Lewy bodies, and …

[HTML][HTML] Update on statin treatment in patients with neuropsychiatric disorders

R Avan, A Sahebnasagh, J Hashemi, M Monajati… - Life, 2021 - mdpi.com
Statins are widely accepted as first-choice agents for the prevention of lipid-related
cardiovascular diseases. These drugs have both anti-inflammatory and anti-oxidant …

Effects of statins on dopamine loss and prognosis in Parkinson's disease

SH Jeong, HS Lee, SJ Chung, HS Yoo, JH Jung… - Brain, 2021 - academic.oup.com
Statins are more widely used not only for the primary and secondary prevention of
cardiovascular disease by blocking cholesterol biosynthesis but also for the potential …

Association of hydroxylmethyl glutaryl coenzyme A reductase inhibitors, L-type calcium channel antagonists, and biguanides with rates of psychiatric hospitalization …

JF Hayes, A Lundin, S Wicks, G Lewis… - JAMA …, 2019 - jamanetwork.com
Importance Drug repurposing is potentially cost-effective, low risk, and necessary in
psychiatric drug development. The availability of large, routine data sets provides the …

Adjunctive therapy with statins in schizophrenia patients: a meta-analysis and implications

H Shen, R Li, R Yan, X Zhou, X Feng, M Zhao… - Psychiatry Research, 2018 - Elsevier
There are some conflicting results regarding the benefit of adjunctive therapy with statins for
severity of negative symptoms in schizophrenia. This study aimed to verify whether statins …

Cholesterol–a putative endogenous contributor towards Parkinson's disease

R Paul, A Choudhury, A Borah - Neurochemistry international, 2015 - Elsevier
Elevated levels of cholesterol and its metabolites (oxysterols) have been reported to be
associated not only with several metabolic syndromes, but also become a prognostic risk …

High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain

Q Wang, A Zengin, C Deng, Y Li, KA Newell… - Experimental …, 2009 - Elsevier
Statins are widely being used for the treatment of a variety of conditions beyond their original
indication for lowering cholesterol. We have previously reported that simvastatin affected the …

[HTML][HTML] The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action

YM Vuu, A Kadar Shahib, M Rastegar - Pharmaceuticals, 2023 - mdpi.com
Statins are common drugs that are clinically used to reduce elevated plasma cholesterol
levels. Based on their solubility, statins are considered to be either hydrophilic or lipophilic …

Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management

M Tuccori, S Montagnani, S Mantarro… - Cns Drugs, 2014 - Springer
Abstract Statins, or 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, such as
lovastatin, atorvastatin, simvastatin, pravastatin, fluvastatin, rosuvastatin and pitavastatin, are …

Statin therapy prevents the onset of Parkinson disease in patients with diabetes

KD Lin, CY Yang, MY Lee, SC Ho, CK Liu… - Annals of …, 2016 - Wiley Online Library
Objective We studied the association between the statin dosage and the risk of Parkinson
disease (PD) in diabetic patients in Taiwan. Methods One million patients were randomly …